This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Activity Details
73 * | Sun, 8/1/2010, 4:00 PM - 5:50 PM | CC-208 (West) |
Various Topics in Clinical Trials — Contributed Papers | ||
Biopharmaceutical Section | ||
Chair(s): Samir Lababidi, FDA | ||
4:05 PM | Phase I Studies: Goals, Patient Selection, and Implications for Design — Paul H. Frankel, City of Hope ; Stephen Shibata, City of Hope ; Susan Groshen, University of Southern California, Norris ; Jeffrey Longmate, City of Hope ; Stella Khoo, City of Hope ; Edward Newman, City of Hope | |
4:20 PM | An Evaluation of a Simon 2-Stage Phase II Clinical Trial Design Incorporating Continuous Toxicity Monitoring — Herman Ray, University of Louisville ; Shesh Rai, University of Louisville | |
4:35 PM | Exact Two-Stage Designs for Phase II Clinical Trials with Rank-Based Endpoints — Gregory E. Wilding, State University of New York at Buffalo ; Guogen Shan, State University of New York at Buffalo ; Alan Hutson, State University of New York at Buffalo | |
4:50 PM | Quantile Regression Extended to Mixed Models — Michelle Quinlan, University of Nebraska-Lincoln ; Walt Stroup, University of Nebraska-Lincoln | |
5:05 PM | Robust Parametric Classification and Variable Selection — Eric Chi, Rice University ; David W. Scott, Rice University | |
5:20 PM | Two-locus Analysis for Genome-wide Association Studies — Shurong Fang, Michigan Technological University ; Qiuying Sha, Michigan Technological University | |
5:35 PM | Floor Discussion |
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.